Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Austin, United States, April 16, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Vaccine Technologies Market size was valued at USD 55.53 Billion in 2025 and is projected to reach USD 153.30...
-
ATHENS, Greece, April 16, 2026 (GLOBE NEWSWIRE) -- Performance Shipping Inc. (NASDAQ: PSHG), (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, today...
-
International Red Dot Jury recognizes Nanox.ARC X for design excellence that brings advanced 3D tomosynthesis imaging into a wider range of clinical settings PETACH TIKVA, ISRAEL - 16 April, 2026 -...
-
AGOURA HILLS, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a clinical-stage biopharmaceutical company developing drugs...
-
Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Global Healthcare Cold Chain Logistics Market Report & Forecast 2026-2034" has been added to ResearchAndMarkets.com's offering.The global...
-
Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "POS Software Market Report by Component, Type, Deployment Mode, Organization Size, Application, End User, and Region 2026-2034" has been added to ...
-
Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "The U.S. Mental Health Treatment Market 2026: Outpatient & Inpatient Facilities, Apps & Therapists" report from Marketdata LLC has been added...
-
BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
BASEL, Switzerland, April 16, 2026 (GLOBE NEWSWIRE) -- BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated...
-
Austin, TX, USA, April 16, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Vacuum Skin Packaging Market Size, Trends and Insights By Type (Flat Skin...
-
Tivoxavir marboxil advancing towards a human influenza challenge trial as a once-monthly prophylactic agent, building on broad preclinical antiviral activity, Ratutrelvir topline Phase 2a data show...